IranPharmis proudly participated in the 44th Congress of the Iranian Society of Surgeons, held from May 13–17, 2023, at the Razi International Conference Center in Tehran.
Recognized as one of Iran’s most prestigious scientific gatherings in the field of surgery, the event provided an exceptional opportunity for IranPharmis to present its latest innovations in surgical and medical equipment, connect with healthcare professionals, and reinforce its mission of advancing clinical outcomes and supporting the continuous development of the country’s healthcare system.
The “44th Congress of the
Iranian Society of Surgeons” was held from May 13–17, 2023, at the “Razi
International Conference Center” in Tehran.
As one of the most
significant national gatherings in the field of surgery, this congress provided
an exceptional platform for scientific exchange, presentation of cutting-edge
technologies, and professional collaboration among surgeons, university
professors, and leading companies in the medical equipment industry.
Purpose of IranPharmis’
Participation
IranPharmis joined this
distinguished event with the aim of introducing its latest medical and surgical
technologies, establishing direct connections with healthcare professionals,
and offering innovative solutions to enhance the quality and efficiency of
clinical care.
The company’s
participation underscored its ongoing commitment to quality, innovation, and
scientific collaboration—a mission centered on improving treatment outcomes and
advancing public health standards.
IranPharmis’ Activities
and Highlights
Throughout the congress,
IranPharmis conducted a series of specialized presentations and professional
engagements, which drew significant attention and appreciation from attending
surgeons and medical experts. Key activities included:
Presentation of advanced
surgical instruments featuring ergonomic designs and exceptional precision,
Showcasing
internationally certified medical consumables designed to meet the needs of modern
healthcare environment,
Specialized discussions
with surgeons and hospital managers to exchange professional insights and
gather scientific feedback,
Distribution of
educational brochures and technical consultations to familiarize specialists
with IranPharmis’ product portfolio.
Key Achievements of
IranPharmis at the Congress
- Expanding professional and strategic connections with medical specialists
and industry decision-makers,
- Enhancing brand visibility and reputation, reinforcing IranPharmis’
leadership in the surgical equipment market,
- Sharing scientific knowledge and practical experience with experts in
surgery and medical technology,
- Exchanging ideas and fostering innovation to inspire the development of new
and improved medical products.
Engagement and
Feedback
IranPharmis’ active participation
created a valuable platform for close interaction with esteemed professors,
surgeons, hospital administrators, and professionals in the medical equipment
industry.
Visitors expressed strong
appreciation for the high quality, precision, and user-friendly design of
IranPharmis products—praising them as a reflection of the company’s
technological advancement and expertise in the field of surgical equipment.
This positive feedback
provided clear direction for future product development and service
enhancement, further strengthening IranPharmis’ position as a trusted and
respected brand within Iran’s medical community.
Future Vision and
Conclusion
Building upon the
relationships and insights gained during the congress, “IranPharmis” plans to expand
its scientific and commercial collaborations with hospitals and healthcare
institutions across the country.
In the future, the
company will continue to focus on:
- Developing more efficient
and reliable medical products,
- Supplying high-quality
surgical equipment that meets global standards, and
- Expanding research-based
partnerships to support the continuous advancement of healthcare services in
Iran.
Through its participation in the “44th Congress of the Iranian Society of
Surgeons”, IranPharmis once again demonstrated its dedication to innovation,
excellence, and meaningful support for the nation’s medical community.